A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck-Reference-Cited by-同舟云学术

A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck

Published:2019-03 Issue: Volume:90 Page:80-86
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Ward Matthew C.,Lee Nancy Y.,Caudell Jimmy J.,Zajichek Alexander,Awan Musaddiq J.,Koyfman Shlomo A.,Dunlap Neal E.,Zakem Sara J.,Hassanzadeh Comron,Marcrom Samuel,Boggs Drexell H.,Isrow Derek,Vargo John A.,Heron Dwight E.,Siddiqui Farzan,Bonner James A.,Beitler Jonathan J.,Yao Min,Trotti Andy M.,Riaz Nadeem

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference16 articles.

1. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

2. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

3. Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer;Beitler;Int J Radiat Oncol Biol Phys,2014

4. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck;Spencer;Head Neck,2008

5. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group protocol 9911;Langer;J Clin Oncol,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on: Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer;Radiotherapy and Oncology;2024-10

2. Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer;Radiotherapy and Oncology;2024-07

3. Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma;JAMA Oncology;2024-07-01

4. Optimising (Re-)Irradiation for Locally Recurrent Head and Neck Cancer: Impact of Dose-Escalation, Salvage Surgery, PEG Tube Dependence and Biomarkers on Oncological Outcomes;2024-04-08

5. Role of radiotherapy and re-irradiation in recurrence and metastatic disease;Revisiones en Cáncer;2024